Hussman Strategic Advisors’s Rigel Pharmaceuticals RIGL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q2 | – | Sell |
-15,600
| Closed | -$206K | – | 335 |
|
|
2023
Q1 | $206K | Hold |
15,600
| – | – | 0.03% | 294 |
|
|
2022
Q4 | $234K | Hold |
15,600
| – | – | 0.04% | 278 |
|
|
2022
Q3 | $184K | Hold |
15,600
| – | – | 0.03% | 276 |
|
|
2022
Q2 | $176K | Hold |
15,600
| – | – | 0.03% | 289 |
|
|
2022
Q1 | $466K | Hold |
15,600
| – | – | 0.09% | 262 |
|
|
2021
Q4 | $413K | Buy |
+15,600
| New | +$413K | 0.09% | 262 |
|